Circulating T-cells from r/r MM patients are known to have significantly abundant PD-1 and LAG3 expression, in which higher expression levels are predictive of poorer patient survival, suggesting a role for targeting these checkpoint molecules (59, 60). The gene discussed is LAG3; the disease is Miyoshi myopathy.